We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Scientists Unwind More Mysteries of the Cellular Clock

By LabMedica International staff writers
Posted on 08 Dec 2014
Print article
Image: Color coding of genes activated in the liver (yellow) as waves of their activation relative to the time of day. Zeitbeger times (ZT):  ZT0= 7 am, ZT3=10 am, ZT6=1 pm, etc. (Photo courtesy of Dr. Bin Fang, Perelman School of Medicine, University of Pennsylvania).
Image: Color coding of genes activated in the liver (yellow) as waves of their activation relative to the time of day. Zeitbeger times (ZT): ZT0= 7 am, ZT3=10 am, ZT6=1 pm, etc. (Photo courtesy of Dr. Bin Fang, Perelman School of Medicine, University of Pennsylvania).
A new study surveying circadian gene expression provides a new understanding of how one clock leads to at least 8 different subclocks, and may suggest a new venue for drug treatment of clock-based metabolic disorders.

Human existence is basically circadian in that most people wake in the morning, sleep in the evening, and eat in between. Body temperature, metabolism, and hormone levels all fluctuate throughout the day and disruption of those cycles can lead to disorders and diseases. The wheels and springs of the molecular clock underlying these circadian rhythms include transcription factors (TFs) that control oscillation of expression of circadian genes.

Not all circadian cycles peak at the same time – some peak in the morning, others in the evening, etc. The question is how does a single clock keep time in multiple phases at once? 

New findings come from the team of Mitchell Lazar, MD, PhD, and professor at the University of Pennsylvania’s Perelman School of Medicine (Philadelphia, PA, USA) in a report of a genome-wide survey of circadian protein-coding genes and gene-expression enhancers, parts of the “dark matter” of the genome in that they don’t encode for proteins. The team took advantage of new tools based on high-density DNA sequencing to measure the activity of enhancers throughout the day in the livers of mice. They found that many enhancers, like circadian genes themselves, have a daily oscillation that is in phase with nearby genes – both the enhancer and gene activity peak at the same time each day. The activities of the enhancers themselves are, in turn, governed by distinct TFs.

Grouping the enhancers into 8, 3-hour phases based on when they peak, the team asked which TFs are capable of binding to the enhancers in each set. Remarkably, the team found that enhancers that are in the same phase tend to be bound by the same TFs. For instance, one circadian component, CLOCK, binds enhancers that are most active during one particular 3-hour period. Another protein, Rev-erba, binds 12 hours later. Loss of any one of the TFs dysregulates a subset of oscillating genes while leaving genes tuned to other circadian phases unaffected.

“Different transcription factors control different phases,” said Lazar, “That explains how one clock leads to at least 8 different subclocks.”

Also important is that genes that oscillate with the same phase tend to have related functions, which are distinct from the pathways controlled at other times. Genes involved in insulin signaling peak at a different time than genes that control sugar metabolism, for instance.

Lazar suggests it might be possible to tweak pharmaceutical regimens to make them more efficient by delivering drugs only when the pathways they impact are actually active – a strategy that could minimize unintended side effects. Toward “a proof-of-concept for a new principle of drug treatment for metabolic disorders,” he said, “this is a real step in that direction.”

The study, by Fang B, Everett L, Jager J, et al., was published in the journal Cell, online ahead of print November 20, 2014.

Related Links:

Perelman School of Medicine at the University of Pennsylvania
University of Pennsylvania Health System 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Strips
11 Parameter Urine Strips
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.